Beckford Search https://validator.w3.org/feed/docs/rss2.html Massachusetts Biopharma Industry Hiring at a Record Rate Star Pfizer Scientist is New Biogen R&D Chief Postapproval CMC Changes: FDA Updates Guidance Former Shire Exec New ImmunoGen CEO Profile & Case Study Testimonials Biography Top 10 US Biopharma Clusters Pfizer’s $911M discovery pact with WaVe Life Sciences Octapharma AG Invests €80 Million Exciting European Immunotherapy News Ariad Sells Off Europe Hub, Drug Rights in $140M Incyte Deal Industry concern over Brexit Merck appoints ex-Pfizer exec as global head of oncology Oxford University spin-off OxStem gains record funding ImmunoGen Appoints Mark J. Enyedy as President & CEO TC Therapeutics appoints Tuyen Ong as chief medical officer Takeda Appoints James Kehoe as CFO/COO Valeant Names Joseph Papa as New CEO Tips for Improving Employee-Employer Relationships The week in M&A Cambridge Healthtech Institute’s Annual World Preclinical Congress Promethera Biosciences acquires key assets of Cytonet Merck Gets FDA Breakthrough Therapy Designation Onxeo-CIMA Tie-in to test lead Oncology Compounds CRISPR biotech Intellia strikes licensing deal with Regeneron Adaptimmune and GSK expand Strategic Immunotherapy Collaboration Macrophages surrounding lymph nodes block the progression of melanoma, other cancers Swedish Startup close to the North Pole signs 100 million deal with AstraZeneca Flatiron Health Announces Strategic Relationships With Celgene (CELG) And Amgen (AMGN Shire to expand biotechnology manufacturing capacity in Ireland EMVO appoints new general manager Insight 5 Insight 3 U.K. Aims at $15B Gene Therapy Industry ACTELION RECEIVES POSITIVE CHMP OPINION FOR UPTRAVI FOR THE LONG-TERM TREATMENT OF PULMONARY ARTERIAL HYPERTENSION Track record Insight 4 NCCN Awarded $2 Million in Research Funding from Infinity Pharmaceuticals Cancer Immunotherapy May Improve with Identification of New Mutations BAVARIAN NORDIC ENTERS RESEARCH COLLABORATION TO DEVELOP MRSA VACCINE POZEN And Tribute Combine To Create Aralez Pharmaceuticals Inc. Sanofi and Merck call it quits on vaccines JV after 20 years SANOFI APPOINTS MUZAMMIL MANSURI TO EXECUTIVE COMMITTEE AND EXECUTIVE VICE PRESIDENT, STRATEGY & BUSINESS DEVELOPMENT Sarepta shrinks as execs wait for FDA’s decision on Duchenne drug Teva and AbCellera Enter Into Agreement to Discover Rare Monoclonal Antibodies French investigators Blast Biotrial Over Fatalities Two Big CEO Shifts. FDA Rejects Market Application for Biomarin’s Duchenne’s Drug Home